This multicenter prospective clinical study focuses on elderly patients with lung cancer. We will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens, construct multidisciplinary perioperative comprehensive therapy, integrated Chinese-Western medicine full-cycle management and personalized postoperative rehabilitation systems, so as to form a whole-process optimized treatment model for elderly lung cancer.
Aged ≥65 years old
Pathologically confirmed non-small cell lung cancer with clinical stage eligible for curative surgical resection
Complete preoperative geriatric comprehensive assessment data available
Capable of finishing planned surgery and long-term follow-up
History of other malignant tumors within recent 5 years
Severe organic dysfunction of heart, liver, renal or respiratory system that cannot tolerate thoracic surgery
Preoperative confirmed distant metastasis preventing radical resection
Uncontrolled active severe infection or obvious coagulation disorders